Georg Büchner
Group Chief Business Officer
Biography
- +20 years of experience in science, business, corporate development and consulting positions within academia and the pharmaceutical business
- In the past worked in various Biotechs and had its own consulting firm, with his involvement spanning start-ups, where he led the sale of Haptogen to Wyeth; to private and public biotechs, including at Amgen INC., where he was the BD responsible for Italy, Israel, UK, France and Scandinavia
- Experience encompasses M&A, private and public fund raising, corporate and business strategy, service business and product/technology in/out-licencing from preclinical to market stage
- Holds an MBA from the Judge Cambridge University (UK), a PhD in Molecular and Developmental Biology from Kings College London
Helsinn's Senior Executive Committee
Riccardo Braglia
Executive Chairman
Konrad Wilson
Group Chief Financial Officer
Dr. Melanie Rolli
Group Chief Executive Officer
Giorgio Calderari
Vice Chairman
Matteo Missaglia
Group General Counsel, Group Chief Legal Officer
Sergio Cantoreggi
Group Chief Scientific Officer, Global Head of R&D
Georg Büchner
Group Chief Business Officer
Roberta Cannella
Group Chief Manufacturing Officer